LivaNova PLC (LIVN)
USD 35.56
(-5.14%)
USD 35.56
(-5.14%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 2.42 Billion USD | 5.87% |
| 2022 | 2.29 Billion USD | 4.26% |
| 2021 | 2.2 Billion USD | -8.73% |
| 2020 | 2.41 Billion USD | -0.02% |
| 2019 | 2.41 Billion USD | -5.41% |
| 2018 | 2.54 Billion USD | 1.83% |
| 2017 | 2.5 Billion USD | 6.89% |
| 2016 | 2.34 Billion USD | -8.45% |
| 2015 | 2.55 Billion USD | 769.75% |
| 2014 | 294.19 Million USD | 11.42% |
| 2013 | 264.04 Million USD | 24.6% |
| 2012 | 211.9 Million USD | 0.21% |
| 2011 | 211.46 Million USD | 35.76% |
| 2010 | 155.76 Million USD | 39.02% |
| 2009 | 112.04 Million USD | -17.75% |
| 2008 | 136.23 Million USD | -1.03% |
| 2007 | 137.64 Million USD | -9.62% |
| 2006 | 152.3 Million USD | 54.06% |
| 2005 | 98.85 Million USD | 4.83% |
| 2004 | 94.29 Million USD | 25.8% |
| 2003 | 74.95 Million USD | 16.53% |
| 2002 | 64.32 Million USD | -17.87% |
| 2001 | 78.31 Million USD | 75.58% |
| 2000 | 44.6 Million USD | 12.07% |
| 1999 | 39.8 Million USD | -24.33% |
| 1998 | 52.6 Million USD | 415.69% |
| 1997 | 10.2 Million USD | 161.54% |
| 1996 | 3.9 Million USD | -71.32% |
| 1995 | 13.6 Million USD | -31.31% |
| 1994 | 19.8 Million USD | -21.43% |
| 1993 | 25.2 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 2.45 Billion USD | 1.24% |
| 2024 Q3 | 2.52 Billion USD | 2.8% |
| 2024 Q2 | 2.45 Billion USD | -0.26% |
| 2023 FY | 2.42 Billion USD | 5.87% |
| 2023 Q1 | 2.29 Billion USD | 0.0% |
| 2023 Q2 | 2.34 Billion USD | 2.03% |
| 2023 Q3 | 2.32 Billion USD | -0.52% |
| 2023 Q4 | 2.42 Billion USD | 4.3% |
| 2022 Q3 | 2.21 Billion USD | -5.28% |
| 2022 FY | 2.29 Billion USD | 4.26% |
| 2022 Q1 | 2.41 Billion USD | 9.81% |
| 2022 Q4 | 2.29 Billion USD | 3.7% |
| 2022 Q2 | 2.33 Billion USD | -3.34% |
| 2021 Q3 | 2.2 Billion USD | -8.06% |
| 2021 Q4 | 2.2 Billion USD | -0.11% |
| 2021 Q1 | 2.36 Billion USD | -1.75% |
| 2021 FY | 2.2 Billion USD | -8.73% |
| 2021 Q2 | 2.39 Billion USD | 1.15% |
| 2020 Q4 | 2.41 Billion USD | -4.38% |
| 2020 FY | 2.41 Billion USD | -0.02% |
| 2020 Q3 | 2.52 Billion USD | 0.76% |
| 2020 Q2 | 2.5 Billion USD | 1.97% |
| 2020 Q1 | 2.45 Billion USD | 1.77% |
| 2019 Q2 | 2.62 Billion USD | 0.85% |
| 2019 Q1 | 2.59 Billion USD | 1.95% |
| 2019 Q4 | 2.41 Billion USD | -3.91% |
| 2019 Q3 | 2.5 Billion USD | -4.26% |
| 2019 FY | 2.41 Billion USD | -5.41% |
| 2018 FY | 2.54 Billion USD | 1.83% |
| 2018 Q4 | 2.54 Billion USD | -2.34% |
| 2018 Q3 | 2.61 Billion USD | 0.52% |
| 2018 Q2 | 2.59 Billion USD | -3.99% |
| 2018 Q1 | 2.7 Billion USD | 8.03% |
| 2017 Q1 | 2.37 Billion USD | 1.2% |
| 2017 FY | 2.5 Billion USD | 6.89% |
| 2017 Q4 | 2.5 Billion USD | -3.81% |
| 2017 Q3 | 2.6 Billion USD | 2.74% |
| 2017 Q2 | 2.53 Billion USD | 6.88% |
| 2016 FY | 2.34 Billion USD | -8.45% |
| 2016 Q4 | 2.34 Billion USD | -6.18% |
| 2016 Q2 | 2.52 Billion USD | -3.09% |
| 2016 Q1 | 2.6 Billion USD | 1.83% |
| 2016 Q3 | 2.49 Billion USD | -1.11% |
| 2015 Q4 | 2.55 Billion USD | 615.44% |
| 2015 Q3 | 357.64 Million USD | 5.74% |
| 2015 Q2 | 338.22 Million USD | 7.05% |
| 2015 Q1 | 315.94 Million USD | 4.83% |
| 2015 FY | 2.55 Billion USD | 769.75% |
| 2014 FY | 294.19 Million USD | 11.42% |
| 2014 Q4 | 301.38 Million USD | 1.56% |
| 2014 Q3 | 296.74 Million USD | 2.35% |
| 2014 Q2 | 289.92 Million USD | -1.45% |
| 2014 Q1 | 294.19 Million USD | 9.29% |
| 2013 Q4 | 269.18 Million USD | 1.32% |
| 2013 FY | 264.04 Million USD | 24.6% |
| 2013 Q3 | 265.68 Million USD | -0.04% |
| 2013 Q2 | 265.79 Million USD | 0.66% |
| 2013 Q1 | 264.04 Million USD | 5.44% |
| 2012 Q1 | 211.9 Million USD | 7.12% |
| 2012 Q2 | 212.82 Million USD | 0.43% |
| 2012 FY | 211.9 Million USD | 0.21% |
| 2012 Q4 | 250.41 Million USD | 7.23% |
| 2012 Q3 | 233.52 Million USD | 9.73% |
| 2011 Q2 | 199.9 Million USD | -5.47% |
| 2011 Q4 | 197.81 Million USD | 0.06% |
| 2011 FY | 211.46 Million USD | 35.76% |
| 2011 Q1 | 211.46 Million USD | 1.93% |
| 2011 Q3 | 197.69 Million USD | -1.11% |
| 2010 Q2 | 151.26 Million USD | -2.89% |
| 2010 Q1 | 155.76 Million USD | 6.53% |
| 2010 Q4 | 207.46 Million USD | 7.96% |
| 2010 Q3 | 192.17 Million USD | 27.04% |
| 2010 FY | 155.76 Million USD | 39.02% |
| 2009 Q1 | 112.04 Million USD | 6.52% |
| 2009 Q2 | 105.62 Million USD | -5.73% |
| 2009 Q3 | 151.15 Million USD | 43.1% |
| 2009 Q4 | 146.21 Million USD | -3.27% |
| 2009 FY | 112.04 Million USD | -17.75% |
| 2008 FY | 136.23 Million USD | -1.03% |
| 2008 Q3 | 112.46 Million USD | -21.75% |
| 2008 Q1 | 136.23 Million USD | -0.0% |
| 2008 Q2 | 143.73 Million USD | 5.51% |
| 2008 Q4 | 105.18 Million USD | -6.47% |
| 2007 Q4 | 136.23 Million USD | 3.35% |
| 2007 Q2 | 134.78 Million USD | -2.08% |
| 2007 FY | 137.64 Million USD | -9.62% |
| 2007 Q1 | 137.64 Million USD | -0.99% |
| 2007 Q3 | 131.81 Million USD | -2.2% |
| 2006 Q4 | 139.01 Million USD | -7.36% |
| 2006 Q3 | 150.06 Million USD | -1.83% |
| 2006 Q2 | 152.86 Million USD | 0.37% |
| 2006 Q1 | 152.3 Million USD | -2.99% |
| 2006 FY | 152.3 Million USD | 54.06% |
| 2005 FY | 98.85 Million USD | 4.83% |
| 2005 Q4 | 156.99 Million USD | -8.18% |
| 2005 Q3 | 170.97 Million USD | 102.39% |
| 2005 Q2 | 84.48 Million USD | -14.54% |
| 2005 Q1 | 98.85 Million USD | 9.65% |
| 2004 Q1 | 94.29 Million USD | -0.84% |
| 2004 FY | 94.29 Million USD | 25.8% |
| 2004 Q4 | 90.15 Million USD | 2.38% |
| 2004 Q3 | 88.06 Million USD | -8.21% |
| 2004 Q2 | 95.93 Million USD | 1.74% |
| 2003 FY | 74.95 Million USD | 16.53% |
| 2003 Q3 | 88.52 Million USD | 14.33% |
| 2003 Q2 | 77.43 Million USD | 3.31% |
| 2003 Q1 | 74.95 Million USD | 7.24% |
| 2003 Q4 | 95.09 Million USD | 7.42% |
| 2002 Q3 | 66.93 Million USD | 6.46% |
| 2002 Q2 | 62.86 Million USD | -2.26% |
| 2002 Q1 | 64.32 Million USD | -5.39% |
| 2002 FY | 64.32 Million USD | -17.87% |
| 2002 Q4 | 69.89 Million USD | 4.43% |
| 2001 Q3 | 71.27 Million USD | 2.35% |
| 2001 Q2 | 69.63 Million USD | -16.15% |
| 2001 Q1 | 83.05 Million USD | 107.64% |
| 2001 FY | 78.31 Million USD | 75.58% |
| 2001 Q4 | 67.98 Million USD | -4.61% |
| 2000 Q2 | 44.6 Million USD | -1.39% |
| 2000 FY | 44.6 Million USD | 12.07% |
| 2000 Q3 | 44.58 Million USD | -0.04% |
| 2000 Q4 | 39.99 Million USD | -10.29% |
| 2000 Q1 | 45.23 Million USD | 15.69% |
| 1999 Q1 | 38.2 Million USD | -9.26% |
| 1999 Q4 | 39.1 Million USD | 2.89% |
| 1999 Q3 | 38 Million USD | -4.52% |
| 1999 FY | 39.8 Million USD | -24.33% |
| 1999 Q2 | 39.8 Million USD | 4.19% |
| 1998 Q1 | 53.3 Million USD | 1.33% |
| 1998 Q3 | 44.7 Million USD | -15.02% |
| 1998 FY | 52.6 Million USD | 415.69% |
| 1998 Q4 | 42.1 Million USD | -5.82% |
| 1998 Q2 | 52.6 Million USD | -1.31% |
| 1997 Q4 | 52.6 Million USD | 2.73% |
| 1997 Q2 | 10.2 Million USD | -25.0% |
| 1997 Q1 | 13.6 Million USD | 40.21% |
| 1997 FY | 10.2 Million USD | 161.54% |
| 1997 Q3 | 51.2 Million USD | 401.96% |
| 1996 Q4 | 9.7 Million USD | -22.4% |
| 1996 Q2 | 3.9 Million USD | -37.1% |
| 1996 Q1 | 6.2 Million USD | -36.73% |
| 1996 FY | 3.9 Million USD | -71.32% |
| 1996 Q3 | 12.5 Million USD | 220.51% |
| 1995 Q3 | 11.7 Million USD | -13.97% |
| 1995 FY | 13.6 Million USD | -31.31% |
| 1995 Q1 | 15 Million USD | -9.64% |
| 1995 Q2 | 13.6 Million USD | -9.33% |
| 1995 Q4 | 9.8 Million USD | -16.24% |
| 1994 Q2 | 19.8 Million USD | -5.71% |
| 1994 Q1 | 21 Million USD | -5.41% |
| 1994 Q3 | 18.1 Million USD | -8.59% |
| 1994 FY | 19.8 Million USD | -21.43% |
| 1994 Q4 | 16.6 Million USD | -8.29% |
| 1993 Q3 | 23.8 Million USD | -5.56% |
| 1993 Q4 | 22.2 Million USD | -6.72% |
| 1993 Q1 | 26.7 Million USD | 0.0% |
| 1993 Q2 | 25.2 Million USD | -5.62% |
| 1993 FY | 25.2 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 31.36 Million USD | -7645.849% |
| BrainsWay Ltd. | 62.97 Million USD | -3758.164% |
| Cerus Corporation | 197.74 Million USD | -1128.616% |
| Envoy Medical, Inc. | 7.64 Million USD | -31700.563% |
| electroCore, Inc. | 16.38 Million USD | -14726.161% |
| Helius Medical Technologies, Inc. | 7.69 Million USD | -31485.582% |
| IceCure Medical Ltd | 16.41 Million USD | -14705.381% |
| Inogen, Inc. | 326.19 Million USD | -644.821% |
| OrthoPediatrics Corp. | 449.58 Million USD | -440.4% |
| Lucid Diagnostics Inc. | 27.27 Million USD | -8809.289% |
| Monogram Orthopaedics, Inc. | 16.57 Million USD | -14554.453% |
| MaxCyte, Inc. | 268.27 Million USD | -805.627% |
| NeuroOne Medical Technologies Corporation | 8.09 Million USD | -29904.555% |
| Nexalin Technology, Inc. | 3.63 Million USD | -66794.802% |
| Orthofix Medical Inc. | 925.31 Million USD | -162.566% |
| PAVmed Inc | 33.11 Million USD | -7235.859% |
| Rapid Micro Biosystems, Inc. | 143.45 Million USD | -1593.642% |
| RxSight, Inc. | 182.55 Million USD | -1230.903% |
| Sight Sciences, Inc. | 166.65 Million USD | -1357.875% |
| SI-BONE, Inc. | 230.42 Million USD | -954.383% |
| TELA Bio, Inc. | 78.04 Million USD | -3012.909% |
| Treace Medical Concepts, Inc. | 251.9 Million USD | -864.468% |
| Vivos Therapeutics, Inc. | 10.73 Million USD | -22542.712% |
| Acutus Medical, Inc. | 53.96 Million USD | -4402.526% |
| Talis Biomedical Corporation | 98.34 Million USD | -2370.575% |
| Spectral AI, Inc. | 10.69 Million USD | -22623.186% |
| Nano-X Imaging Ltd. | 218.64 Million USD | -1011.175% |
| CVRx, Inc. | 115.22 Million USD | -2008.465% |
| DIH Holding US, Inc. Warrants | 58.66 Million USD | -4041.701% |
| PetVivo Holdings, Inc. | 3.11 Million USD | -77889.268% |
| Bioventus Inc. | 810.91 Million USD | -199.609% |
| Venus Concept Inc. | 93.65 Million USD | -2494.19% |
| TriSalus Life Sciences, Inc. | 25.72 Million USD | -9344.365% |
| 908 Devices Inc. | 202.98 Million USD | -1096.941% |
| Alphatec Holdings, Inc. | 805.2 Million USD | -201.731% |
| Nemaura Medical Inc. | 14.56 Million USD | -16582.855% |
| NeuroPace, Inc. | 107.65 Million USD | -2156.888% |
| LENSAR, Inc. | 69.58 Million USD | -3391.504% |
| Apyx Medical Corporation | 79.24 Million USD | -2966.082% |
| Cutera, Inc. | 346.29 Million USD | -601.596% |
| STRATA Skin Sciences, Inc. | 42.01 Million USD | -5682.471% |
| BioSig Technologies, Inc. | 1.79 Million USD | -135025.862% |
| Anika Therapeutics, Inc. | 270.63 Million USD | -797.737% |
| ClearPoint Neuro, Inc. | 42.66 Million USD | -5595.045% |
| Integra LifeSciences Holdings Corporation | 3.78 Billion USD | 35.76% |
| Axonics, Inc. | 719.92 Million USD | -237.475% |
| Outset Medical, Inc. | 313.8 Million USD | -674.237% |
| IRIDEX Corporation | 34.43 Million USD | -6955.3% |
| PROCEPT BioRobotics Corporation | 404.71 Million USD | -500.312% |
| IRadimed Corporation | 92.15 Million USD | -2536.356% |
| Tivic Health Systems, Inc. | 5.25 Million USD | -46142.158% |
| INVO Bioscience, Inc. | 20.88 Million USD | -11531.5% |
| Telesis Bio, Inc. | 70.41 Million USD | -3350.545% |
| Viemed Healthcare, Inc. | 154.1 Million USD | -1476.589% |
| Varex Imaging Corporation | 1.24 Billion USD | -94.427% |
| Quipt Home Medical Corp. | 247.4 Million USD | -882.007% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -25996.273% |
| Pulmonx Corporation | 178.95 Million USD | -1257.669% |
| Dynatronics Corporation | 25.94 Million USD | -9265.885% |
| Modular Medical, Inc. | 13.8 Million USD | -17496.603% |
| ReShape Lifesciences Inc. | 10.72 Million USD | -22549.044% |
| Semler Scientific, Inc. | 78.06 Million USD | -3012.231% |
| InMode Ltd. | 863.28 Million USD | -181.432% |
| Bruker Corporation | 4.24 Billion USD | 42.832% |
| Cytosorbents Corporation | 53.26 Million USD | -4461.649% |
| DexCom, Inc. | 6.26 Billion USD | 61.217% |
| Align Technology, Inc. | 6.08 Billion USD | 60.066% |
| Viveve Medical, Inc. | 25.91 Million USD | -9275.846% |
| ZimVie Inc. | 1.2 Billion USD | -101.566% |
| Movano Inc. | 9.42 Million USD | -25688.802% |
| Cytek Biosciences, Inc. | 497.66 Million USD | -388.189% |
| Nexalin Technology, Inc. | 3.63 Million USD | -66794.802% |
| DIH Holdings US, Inc. Class A Common Stock | 58.66 Million USD | -4041.701% |
| Tandem Diabetes Care, Inc. | 952.65 Million USD | -155.03% |
| Profound Medical Corp. | 43.68 Million USD | -5461.379% |
| Insulet Corporation | 2.58 Billion USD | 6.129% |
| enVVeno Medical Corporation | 48.63 Million USD | -4895.503% |
| Surmodics, Inc. | 185.73 Million USD | -1208.094% |
| iCAD, Inc. | 41.41 Million USD | -5765.959% |
| Nuwellis, Inc. | 9.77 Million USD | -24767.584% |
| Biotricity, Inc. | 5.94 Million USD | -40783.667% |
| iRhythm Technologies, Inc. | 433.14 Million USD | -460.913% |
| Aethlon Medical, Inc. | 8.24 Million USD | -29363.598% |
| InspireMD, Inc. | 47.64 Million USD | -4999.517% |
| PAVmed Inc. | 33.11 Million USD | -7235.859% |
| BIOLASE, Inc. | 35.1 Million USD | -6821.635% |
| Beyond Air, Inc. | 56.96 Million USD | -4165.31% |
| FONAR Corporation | 214.24 Million USD | -1034.006% |
| AxoGen, Inc. | 196.82 Million USD | -1134.365% |
| Vivani Medical, Inc. | 45.79 Million USD | -5205.07% |
| Tactile Systems Technology, Inc. | 281.43 Million USD | -763.268% |
| Inari Medical, Inc. | 674.23 Million USD | -260.344% |
| UFP Technologies, Inc. | 404.13 Million USD | -501.175% |
| QT Imaging Holdings, Inc. | 23.39 Million USD | -10283.386% |
| Heart Test Laboratories, Inc. | 9.5 Million USD | -25465.97% |
| Tenon Medical, Inc. | 6.34 Million USD | -38190.985% |
| Autonomix Medical, Inc. Common Stock | 9.4 Million USD | -25727.182% |
| Co-Diagnostics, Inc. | 103.64 Million USD | -2244.058% |
| AdaptHealth Corp. | 4.61 Billion USD | 47.41% |
| Sintx Technologies, Inc. | 15.36 Million USD | -15712.32% |
| NanoVibronix, Inc. | 6.67 Million USD | -36303.401% |
| Quanterix Corporation | 425.01 Million USD | -471.647% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -25996.273% |
| Sensus Healthcare, Inc. | 53.72 Million USD | -4422.052% |
| Pacific Biosciences of California, Inc. | 1.74 Billion USD | -39.149% |
| TransMedics Group, Inc. | 706.04 Million USD | -244.108% |
| ReWalk Robotics Ltd. | 63.19 Million USD | -3744.732% |
| NeuroMetrix, Inc. | 21.42 Million USD | -11240.147% |
| Hyperfine, Inc. | 94.19 Million USD | -2479.181% |
| Establishment Labs Holdings Inc. | 268.64 Million USD | -804.39% |
| Biomerica, Inc. | 9.25 Million USD | -26154.193% |
| Bone Biologics Corporation | 3.73 Million USD | -64900.456% |
| AVITA Medical, Inc. | 144.33 Million USD | -1583.222% |
| Bluejay Diagnostics, Inc. | 4.86 Million USD | -49803.41% |
| Silk Road Medical, Inc | 265.3 Million USD | -815.748% |